Good news for all you people with heart disease. The heart doctors have managed to find non-surgical cardiac treatment more cheaply. Patients with heart failure can now breathe easier. Now they do not need to run a leaking heart valve surgery procedure which of course painful and high-cost vacuum. NorthShore University Health System in Evanston, Ill., United States, have discovered a new method replaces the operation.

They managed to make a small clip implanted in heart arteries through Laparoscopic surgery. The result, tiny objects called MitraClip Abbott is actually more secure and almost equal effectiveness by surgery. Currently this health device has officially sold in Europe. Company manufacturer, Abbott Laboratories, hoping to win a tender to market in the United States next year.

Hollywood actress Elizabeth Taylor is reported to have had such equipment in the autumn of last year. Women's aging 77-year-old told his fans on social networking site Twitter. Known, about 8 million people in the United States and Europe suffer from heart mitral valve leakage, which is the heart valve between the left upper and lower.

Not all heart patients classified as fatal to require treatment, but the worst cases can lead to heart failure later in life. In the study in mind, heart sufferers who run the operation six times greater risk to suffer complications than those using the MitraClip Abbott.

Death, stroke, and blood transfusion was not a concern to be prevented with this device. Doctors call this discovery as the first major test of heart valve repair or replacement through the blood vessels rather than surgery. For information, MitraClip only to improve mitral valve.

Device for other heart valves are in the final stages of testing and many doctors believe that they will soon be made in the near future. "(What matters) we have opened the door to new therapeutic options for patients," says Dr. Ted Feldman NorthShore University Health System in Evanston, Ill., USA.

Feldman was the leader of the new study and has presented it in front of the American College of Cardiology conference on Sunday (14 / 3). This study was sponsored by Evalve Inc., which developed the device. Evalve sold last year to North Chicago, Ill.,-based Abbott, and Feldman is a consultant for the company.

Some surgeons still not sure this device is as effective as surgery. They say patients should continue to be monitored history of the disease to more than one year. "This is a partial victory for the set," said Dr James McClurken, a surgeon at Temple University in Philadelphia, United States. McClurken is the chairman of the conference committee.

"This study uses an outdated method, which could ignore the benefits are many and have stood the test of the operation," said Dr J Scott Millikan, a surgeon at the Billings Clinic in Montana, United States. However, researchers still insist on this matter. "Clearly this is a very interesting technology," explains Feldman.

However, researchers acknowledge the success of this device will run slower. Known, such as mitral valve entrance that opens to let blood flow to the heart to pump it to every booth. When the flaps of the swinging door is not closed completely, the blood flows back into the upper chamber of the heart. It makes blood flow obstructed.

Drugs can actually relieve heart failure symptoms, but does not fix the valve problem, even worse. Worst case cured with cardiac surgery. Doctors sewed most amid flap so that blood flows in both sides, but they kept pumping in each heartbeat.

MitraClip use of this procedure performed, where patients receiving general anesthesia first. The doctor will push a tube into a blood vessel closing in your groin and took it to heart. MitraClip tools, cloth-covered metal clamps, are mounted at the end of the tube together with two flaps of the valve clip. Results in this study, 184 people agree to use the clip and was successfully operating procedures to 136 people.

Complications occurred in 10 percent of users compared to 57 percent clip from the 79 other patients who were treated with surgery. This is certainly better. Two surgical operations meakukan patients died, two suffered a stroke, and four required emergency heart surgery. However, there are no clips from the patient users who have had problems.

This suggests that the use of MitraClip much safer than surgery. While related effectiveness, this study did not answer further. This study was designed only to see whether the use of the device or not clip lower than the operation substantially.